Pérez-Villavicencio, R.; Flores-Estrada, J.; Franco, M.; Escalante, B.; Pérez-Méndez, O.; Mercado, A.; Bautista-Pérez, R.
Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats. Int. J. Mol. Sci. 2022, 23, 2883.
https://doi.org/10.3390/ijms23052883
AMA Style
Pérez-Villavicencio R, Flores-Estrada J, Franco M, Escalante B, Pérez-Méndez O, Mercado A, Bautista-Pérez R.
Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats. International Journal of Molecular Sciences. 2022; 23(5):2883.
https://doi.org/10.3390/ijms23052883
Chicago/Turabian Style
Pérez-Villavicencio, Roxana, Javier Flores-Estrada, Martha Franco, Bruno Escalante, Oscar Pérez-Méndez, Adriana Mercado, and Rocio Bautista-Pérez.
2022. "Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats" International Journal of Molecular Sciences 23, no. 5: 2883.
https://doi.org/10.3390/ijms23052883
APA Style
Pérez-Villavicencio, R., Flores-Estrada, J., Franco, M., Escalante, B., Pérez-Méndez, O., Mercado, A., & Bautista-Pérez, R.
(2022). Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats. International Journal of Molecular Sciences, 23(5), 2883.
https://doi.org/10.3390/ijms23052883
